Jazz Pharmaceuticals's total assets for Q4 2025 were $11.66B, an increase of 2.67% from the previous quarter. JAZZ total liabilities were $7.34B for the fiscal quarter, a -0.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.